| Jenifer E Mascaro, LCPCC, LADC | |
|
1 Delta Dr, Westbrook, ME 04092-4745 | |
| (207) 856-7227 | |
| (207) 856-2112 |
| Full Name | Jenifer E Mascaro |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 1 Delta Dr, Westbrook, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205123692 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | LC4388 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jenifer E Mascaro, LCPCC, LADC 1 Delta Dr, Westbrook, ME 04092-4745 Ph: (207) 856-7227 | Jenifer E Mascaro, LCPCC, LADC 1 Delta Dr, Westbrook, ME 04092-4745 Ph: (207) 856-7227 |
News Archive
Celgene Corporation today announced that after consultation with the U.S. Food and Drug Administration Celgene will discontinue treatment with REVLIMID (lenalidomide) in the open-label, phase III ORIGIN trial, which enrolled 450 patients in over 100 sites in 26 countries.
Research shows that the degree of sarcomatoid differentiation in patients with grade 4 renal cell carcinoma is not only associated with poor survival, but can also serve as an independent prognostic factor in these patients.
Sanomedics International Holdings, Inc., a medical technology holding company that focuses on game-changing products, services and ideas, today announced that it has completed the previously announced acquisition of Prime Time Medical, Inc., of Largo, Florida for a total purchase price of $3,100,000, effective August 30, 2013.
The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines —produced from healthy and tumour cells from the patient him or herself— and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.
From bench to bedside, the journey towards new cancer therapies is full of challenges. Clinical trials – where new treatments are tested on people – are vital, but with fewer than five per cent of cancer patients participating worldwide, it's a long road to travel.
› Verified 9 days ago
Dustin Howard, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 Delta Dr, Westbrook, ME 04092 Phone: 207-856-7227 | |
Chet Boucher Adams, LADC, CCS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 Delta Dr, Westbrook, ME 04092 Phone: 207-856-7227 Fax: 207-856-2112 | |
Kate Balfour Danielson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 15 Saunders Way, Westbrook, ME 04092 Phone: 207-887-1088 | |
Halen Earle, LCPC, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 116 W Pleasant St, Westbrook, ME 04092 Phone: 802-922-4706 | |
Virginia Walker Bowes, LCPC-C Counselor Medicare: Not Enrolled in Medicare Practice Location: 836 Main St Ste 2, Westbrook, ME 04092 Phone: 207-615-9692 | |
Kathleen C Perkins, CAC5247 Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 Delta Dr, Westbrook, ME 04092 Phone: 207-856-7227 Fax: 207-856-2112 | |
Caroline Louise Davison, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 12 Westbrook Cmn, Westbrook, ME 04092 Phone: 207-856-1500 Fax: 207-856-1518 |